Trial Outcomes & Findings for Pilot Study of Nutrition in Maintenance Hemodialysis Patients (NCT NCT02917278)

NCT ID: NCT02917278

Last Updated: 2021-10-19

Results Overview

frequency of hypotensive events that require intervention during dialysis

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

19 participants

Primary outcome timeframe

9 weeks

Results posted on

2021-10-19

Participant Flow

Participant milestones

Participant milestones
Measure
Meals
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
No Meals
Overall Study
STARTED
10
9
Overall Study
COMPLETED
9
9
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Total
n=18 Participants
Total of all reporting groups
Age, Continuous
66.8 years
STANDARD_DEVIATION 11.4 • n=9 Participants
58.1 years
STANDARD_DEVIATION 19.2 • n=9 Participants
62.4 years
STANDARD_DEVIATION 15.9 • n=18 Participants
Sex: Female, Male
Female
5 Participants
n=9 Participants
5 Participants
n=9 Participants
10 Participants
n=18 Participants
Sex: Female, Male
Male
4 Participants
n=9 Participants
4 Participants
n=9 Participants
8 Participants
n=18 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
9 participants
n=9 Participants
9 participants
n=9 Participants
18 participants
n=18 Participants
Body Mass Index, kg/m^2
34.2 kg/m^2
STANDARD_DEVIATION 10.2 • n=9 Participants
31.1 kg/m^2
STANDARD_DEVIATION 8.0 • n=9 Participants
32.6 kg/m^2
STANDARD_DEVIATION 9.0 • n=18 Participants
Years on Dialysis
3.1 years
STANDARD_DEVIATION 2.0 • n=9 Participants
3.6 years
STANDARD_DEVIATION 3.3 • n=9 Participants
3.3 years
STANDARD_DEVIATION 2.6 • n=18 Participants

PRIMARY outcome

Timeframe: 9 weeks

frequency of hypotensive events that require intervention during dialysis

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Hypotensive Event Frequency
18 events
13 events

SECONDARY outcome

Timeframe: 9 weeks

Average Lowest Mean Arterial Pressure (mm Hg) over 25 dialysis sessions during the study.

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Mean Arterial Pressure (mm Hg)
75 mm Hg
Standard Deviation 8
84 mm Hg
Standard Deviation 11

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Serum Albumin
3.7 g/dL
Standard Deviation 0.3
3.8 g/dL
Standard Deviation 0.3

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Blood Urea Nitrogen
49 mg/dL
Standard Deviation 16
59 mg/dL
Standard Deviation 13

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Serum Creatinine
6.8 mg/dL
Standard Deviation 1.1
7.8 mg/dL
Standard Deviation 4.4

SECONDARY outcome

Timeframe: 9 weeks

Population: Only measured in patients with diabetes mellitus

Outcome measures

Outcome measures
Measure
Meals
n=8 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=6 Participants
No Meals
Blood Glucose
137 mg/dL
Standard Deviation 55
178 mg/dL
Standard Deviation 77

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Serum Adjusted Calcium
9.3 mg/dL
Standard Deviation 0.4
9.3 mg/dL
Standard Deviation 0.6

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Serum Sodium
138 mEq/L
Standard Deviation 2
137 mEq/L
Standard Deviation 3

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Serum Phosphate
5.2 mg/dL
Standard Deviation 0.7
7.0 mg/dL
Standard Deviation 1.7

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Serum Chloride
100 mEq/L
Standard Deviation 2
98 mEq/L
Standard Deviation 3

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Serum CO2
25 mEq/L
Standard Deviation 1
25 mEq/L
Standard Deviation 2

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Serum Pre-albumin
26 mg/dL
Standard Deviation 7
26 mg/dL
Standard Deviation 8

SECONDARY outcome

Timeframe: 9 weeks

Absences out of 25 sessions

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Dialysis Absences
0.9 absences
Standard Deviation 1.1
1.8 absences
Standard Deviation 2.6

SECONDARY outcome

Timeframe: 9 weeks

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Interdialytic Weight Gain
1.8 kg
Standard Deviation 1.1
2.4 kg
Standard Deviation 2.1

SECONDARY outcome

Timeframe: 9 weeks

Vitality measured by SF-36 (Short Form 36 Health Survey) Questionnaire. Minimum-Maximum values 0-100, with higher scores meaning better outcomes.

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Vitality Score
42.94 score on a scale
Standard Deviation 18.30
42.04 score on a scale
Standard Deviation 11.99

SECONDARY outcome

Timeframe: 9 weeks

Sleep Problems Index-II from the Medical Outcomes Study (MOS) Sleep Scale. Minimum-Maximum values 0-100, with higher scores meaning better outcomes.

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Sleep Problems Index
49.04 score on a scale
Standard Deviation 10.2
43.37 score on a scale
Standard Deviation 13.00

SECONDARY outcome

Timeframe: 9 weeks

Hunger rating on a visual analog scale of 0-10 cm. Higher values mean a better outcome.

Outcome measures

Outcome measures
Measure
Meals
n=9 Participants
High-protein renal-specific meals Meals: High Protein renal-specific meals
Control
n=9 Participants
No Meals
Hunger Rating
1.01 units on a scale
Standard Deviation 1.01
3.20 units on a scale
Standard Deviation 1.89

Adverse Events

Meals

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kathleen Hill Gallant

Purdue University

Phone: 765-494-0101

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place